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The main aim of this literature review is to capture the existing knowledge across 
a range of products and players in India’s family planning (FP) market. This review 
looks at literature that exists on each of the players along the value chain and on 
consumers, having studied them in isolation and looked at links between them. 
The product scope of this literature review covers condoms, oral contraceptive pills 
(OCPs), injectable contraceptives (ICs), intra-uterine devices (IUDs), and male and 
female sterilization. The broad reach of this analysis brings different perspectives 
together to provide a complete picture of the current state of the market.
This report does not aim to extrapolate or make forward-looking recommendations 
based on the literature studied. Instead, it focuses on identifying areas that will 
benefit from additional analysis. This document can be particularly useful for field 
practitioners, donors, and other players looking to understand the current state of 
discovery in the India family planning market.
This literature review is divided into four main parts, driven by the roles that various 
actors play in the marketplace rather than by the actors themselves:
1. Manufacturers and marketers 
2. Intermediaries
3. Providers: both service providers (3.1) and outlet providers (3.2)
4. Consumers
INTRODUCTION
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The first three sections as laid out above analyze the roles performed by various 
actors as part of a system. These go beyond the core (demand-supply) functions, 
to involve the supporting environment (elements such as financing, capacity 
building, etc.) and the regulatory framework (informal and formal rules, policy 
and laws) in which these actors exist and interact.
The fourth section looks at the market from a consumer point of view. It uses five 
key dimensions to determine the consumer’s ability to engage in FP: awareness, 
availability and access, affordability, assured quality, and acceptability.
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1.  MANUFACTURERS AND 
MARKETERS
The role of manufacturers and marketers is performed by players that either 
manufacture FP products or market them under different brands. Manufacturers 
include those players operating in India that may or may not market their products 
domestically. Marketers, by contrast, include players that market FP products 
purchased or otherwise obtained from manufacturers, both domestic and foreign. 
While secondary sources on these players exist, they are not abundant and most 
information lies with market players and industry experts.
CORE FUNCTIONS
Manufacturing of FP products in India, historically a public sector undertaking, 
has increasingly become a private sector–led industry. While Government of India 
(GoI)-owned enterprises such as HLL and IDPL remain key players in the domestic 
market, private players have established significant capacities to service both the 
domestic and international markets (multiple references1).
Several large-scale contraceptive manufacturers supply their products to the United 
Nations Population Fund (UNFPA) and other international institutional buyers, as 
well as to the GoI (Ahmed & Sarker, 2014; Armand & Beer, 2006). In fact, many of 
the UNFPA/WHO prequalified condom and IUD manufacturers are based in India 
(UNFPA, 2016).
Marketers are largely private sector operators, with the exception of public sector 
distribution led by the GoI (multiple references). The GoI manages the distribution 
of FP products in its portfolio (condoms, OCPs, IUDs, tubal rings) through the 
public sector supply chain to end consumers (multiple references). In contrast, 
1 Multiple references not cited directly. Please see References section for the full list of sources.
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marketers operating through commercial channels use private sector intermediaries 
to distribute their products (Malarcher & Mehra, 2010).
Social marketing organizations (SMOs)—funded through either private foundations, 
bi-lateral and multilateral donors, or the GoI—borrow strategies from commercial 
marketing to generate demand and make FP products available while influencing 
the social behaviors of their target audience (India e-FP, Issue Brief #6). SMOs are 
also contracted by the National AIDS Control Organization (NACO) to implement 
condom distribution strategies, particularly servicing non-traditional outlets (NTOs) 
and hard-to-reach locations (NACO). In addition, SMO marketers are expected 
to conduct demand-generation activities, ranging from mass- and mid-media 
promotion to communication activities among consumers themselves (Armand & 
Beer, 2006; NACO).
SUPPORT ENVIRONMENT
The Ministry of Health and Family Welfare (MoHFW) monitors quality, especially 
for the products it purchases for public sector distribution, in alignment with the 
World Health Organization’s (WHO) Good Manufacturing Practices (Armand & 
Beer, 2006). For instance, condoms are batch sample tested at the manufacturing 
location and quality tested in retail outlets (Department of AIDS Control, 2013). 
Manufacturers also adhere to guidelines set by other quality assurance agencies, 
like UNFPA and WHO quality standards and ISO certifications (Armand & Beer, 
2006; Malarcher & Mehra, 2010).
GoI tenders greatly prefer manufacturers that offer low prices, and winning 
tenders often depends only on low product prices rather than on product features. 
Therefore, manufacturers that seek to sell products through GoI tenders have a 
strong incentive to decrease costs (Armand & Beer, 2006).
RULES
The India Drugs and Cosmetics Acts of 1940 and 1945 established specific 
regulations for drug manufacturing standards (Tandon, 2010). Similarly, the Drug 
Controller General of India (DCGI) issues guidance related to the manufacture of 
medical products, such as OCPs (Armand & Beer, 2006).
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Drug schedules regulate the quality of different FP products. Whereas Schedule R 
focuses on manufacturing procedures and quality testing methods for condoms 
and “mechanical contraceptives” (Schedule R), Schedules H and K control 
substances and drugs, like OCPs (Armand & Beer, 2006).
Schedule H regulates prescription-only products (Rx) and includes most types of 
OCPs, ICs, and IUDs. Products under this category cannot be advertised to the 
public. On the other hand, Schedule K covers products considered public goods, 
which can therefore be advertised and sold over-the-counter (OTC). Schedule K 
products currently include only condoms and certain kinds of OCPs with specific 
formulations (Armand & Beer, 2006).
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Intermediaries are players that move products through the value chain, taking 
them from manufacturers and marketers to providers. Private sector intermediaries 
include distributors and wholesalers. Distributors receive supplies from the 
manufacturer or CFA (Carrying and Forwarding Agent), and wholesalers sell in bulk 
to service and outlet providers. Although these definitions are not universal, and 
existing literature refers to intermediaries in different ways (e.g., super stockists 
and stockists), hierarchies remain fairly standard across sources.
Public sector intermediaries also play a role in distributing products from central 
procurement agencies out to public facilities. Public sector distribution levels follow 
a set hierarchy and include state warehouses, divisional stores, and district stores. 
Government dispensaries at public sector hospitals also perform a distribution 
function, giving out products to outreach workers. However, they have been 
considered as outlet providers for the purpose of this literature review. As with 
manufacturers and marketers, while literary sources on intermediaries exist, they 
are not abundant and most information can be obtained only from industry 
experts and through primary research.
CORE FUNCTIONS
Both public and private sector distribution channels follow hierarchical systems 
that optimize supply chains. Intermediaries obtain their stock from a wide range 
of manufacturers and marketers, both in the private and public sectors. Free 
distribution products then follow the public sector supply chain while SMO and 
commercially marketed products follow the private sector supply chain (Bill & 
Melinda Gates Foundation, 2011).
2. INTERMEDIARIES
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The MoHFW places orders with manufacturers for products in the public sector 
free distribution channel. Manufacturers ship the products to state warehouses 
as specified by MoHFW demand estimates. Products get passed further down 
the system into divisional stores and district stores, from which they move to 
district hospitals (DHs), urban health centers, primary health centers (PHCs), 
and community health centers (CHCs). Outreach workers (e.g., ASHAs) then 
collect products from these facilities and distribute them to consumers in their 
communities. Consumers can also get FP products from government dispensaries 
at public sector facilities (Bill & Melinda Gates Foundation, 2011).
The MoHFW also places some SMO product orders with manufacturers. Yet 
instead of flowing through the public sector supply chain, products are shipped 
to government medical store depots and then to the state CFA or SMO depot. 
From this point onward, SMOs move the products along through private sector 
channels. Products go to distributors and then to wholesalers, from which retail 
outlets get their stocks. Consumers usually buy products from outlet providers (Bill 
& Melinda Gates Foundation, 2011).
SMOs can also independently place orders with manufacturers. Along with 
products marketed by commercial players, these products move along the private 
sector distribution channel (Bill & Melinda Gates Foundation, 2011). Distributors 
typically stock a single brand or a particular product, as they tend to have category 
or marketer exclusivity. Certain intermediaries also have field salesforces that sell 
products to service and outlet providers (Armand & Beer, 2006). Additionally, 
intermediaries may receive discounted products offered as part of a commercial 
promotion scheme or subsidized through donor funding (Malarcher & Mehra, 
2010).
Wholesalers buy their stock from several distributors and carry multiple brands. 
Products move on to retail outlets and to medical representatives (MRs) who 
promote them to service providers. As stated earlier, most consumers purchase 
products from outlet providers. However, some also receive them from service 
providers, especially in the case of ICs and IUDs (Bill & Melinda Gates Foundation, 
2011).
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SUPPORT ENVIRONMENT
The MoHFW estimates public sector demand based on state-level modern 
contraceptive prevalence rate (mCPR) population estimates using Censuses 2001 
and 2011 as well as product wastage rates. They then allocate supply through 
different distribution channels (Bill & Melinda Gates Foundation, 2011). Besides 
the MoHFW, NACO coordinates its condom distribution through State AIDS 
Prevention and Control Societies (SACS), in association with the National Rural 
Health Mission (NRHM). It has also developed guidelines for the appropriate 
storage and distribution of condoms (NACO).
Inefficiencies in public sector distribution present challenges for intermediaries 
and for players further down the value chain. Delays in order placement by the 
MoHFW and the lack of a fixed order calendar affect the supply of FP products to 
consumers. In addition, district stores do not use accurate, fact-based methods to 
allocate products to players along the value chain. This results in some facilities 
having excess stock, while others face stock-outs. Despite formal coordination 
mechanisms, public sector suppliers are not consistently monitored for compliance 
in the delivery of stock to intermediaries and facilities. Added to that, district stores 
have a limited budget for transportation. They thus often combine the delivery of 
multiple orders to healthcare facilities, rather than delivering products based on 
demand, contributing to frequent stock-outs (Bill & Melinda Gates Foundation, 
2011).
Whereas public sector intermediaries receive guidance from the MoHFW, there 
is no evidence of organized guidance provided to private sector intermediaries. 
Similarly, unlike the centrally coordinated public sector channel, private sector 
intermediaries also lack formal coordination mechanisms (Bill & Melinda Gates 
Foundation, 2011).
RULES
FP policy determines which supply chain different products fall under—public or 
private. For example, the new generation of ICs, Depot Medroxyprogesterone 
Acetate (DMPA), could only be distributed through private sector channels before 
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2016. Although the Federation of Obstetric and Gynaecological Societies of India 
(FOGSI), the DCGI, the United States Food and Drug Administration (USFDA), and 
the WHO have approved it as a safe and effective contraceptive for marketing 
and distribution, it was not available through public sector channels as it was not 
included in the GoI’s FP portfolio until then (Family Planning Division, MoHFW, 
2016; Malarcher & Mehra, 2010). 
The DCGI issues regulations on the distribution of medical products, such as OCPs 
(Armand & Beer, 2006; Malarcher & Mehra, 2010). Beyond that, limited rules exist 
for distribution guidelines of FP products at the intermediary stage.
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3.1 SERVICE PROVIDERS
Service providers are players that directly provide FP services to consumers. For 
the purpose of this literature review, these can be OBGYN, MBBS, or AYUSH 
(Ayurveda, Yoga, Unani, Siddha, and Homeopathy) doctors. However, rural medical 
practitioners (RMPs), sometimes referred to as quacks, also provide FP services to 
consumers, albeit not legally. Service providers operate in the private and public 
sectors—some splitting their time between both—in facilities that range from 
consultation-only clinics and PHC/CHCs to full-service hospitals and DHs.
CORE FUNCTIONS
The services that providers can offer vary depending on their specialization and on 
the type of facility in which they practice (multiple references). 
OBGYN and MBBS doctors are the only providers entitled to offer comprehensive 
FP services. Aside from providing condoms and prescribing OCPs, they can also 
administer ICs. However, until 2016 they did so only at private sector facilities, 
as ICs were not included in the public sector FP choice basket prior to that. 
OBGYN and MBBS doctors can also conduct IUD insertions, at both private and 
public sector facilities, but need a special training for postpartum IUD (PPIUCD) 
insertions (multiple references). They are also the only providers allowed to 
perform sterilization, regardless of whether it takes place at private or public 
sector facilities. MBBS doctors, including those with further qualifications, can 
perform male sterilization and mini-lap female sterilization. In contrast, providers 
offering laparoscopic sterilization must be either OBGYN or MBBS DGO doctors, 
or MBBS doctors with an MS Surgery specialization who have received special 
training (MoHFW, 2015).
3. PROVIDERS
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ASHU (Ayurveda, Siddha, Homeopathy, and Unani) doctors can provide and 
prescribe condoms and OCPs. They can also conduct IUD insertions at private and 
public sector facilities, after completing a special training. Other medical providers 
such as staff nurses, auxiliary nurse midwives (ANMs), and lady health visitors 
(LHVs) can provide condoms and OCPs distributed through public sector channels 
(e.g., Nirodh, Mala-N) and insert IUDs, but only at public sector facilities (multiple 
references).
While public sector facilities offer FP methods free of cost, prices at private facilities 
vary by product and depend on the type of provider and their locality (multiple 
references). Aiming to fill gaps in FP service provisioning, temporary camps (e.g., 
sterilization camps) also take place during specific times of the year, and services 
are generally offered free of cost as well (Pillai & Singh, Urban Health Initiative, 
India: Progress and Results January 2009 to December 2013, 2014).
Although many service providers do not conduct promotional activities, other 
players do dedicated FP promotion. The majority of these are outreach workers 
who operate in specific communities with which they have regular contact 
(multiple references). Most outreach workers in the public sector fall under the 
Accredited Social Health Activist (ASHA) program, and are described further under 
Section 3.2: Outlet Providers (MoHFW, 2015). Private sector outreach workers are 
mostly managed by non-governmental organizations (NGOs) or SMOs, and their 
scope depends on the program they fall under and the product they promote 
(multiple references). 
Certain NGOs conduct promotional activities for FP by training outreach workers, 
peer educators, and FP counselors who then engage with communities. NGO 
outreach workers also do product-use demonstrations—particularly for products 
like condoms—and distribute written material that ties in with NGO-sponsored 
media promotions (NACO; Pillai & Singh, Urban Health Initiative, India: Progress 
and Results January 2009 to December 2013, 2014). The Dimpa Program, for 
example, has used outreach workers to promote ICs, specifically DMPA. Workers 
identify and refer women interested in using DMPA as an FP method, and provide 
systematic follow-up to ensure continued use (Pillai & Singh, Urban Health 
Initiative, India: Progress and Results January 2009 to December 2013, 2014).
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SUPPORT ENVIRONMENT
The MoHFW offers guidance related to service delivery norms and standards for 
different FP products (MoHFW, 2015). Yet though it makes guidance material 
available, it does not actively circulate market information (market size, players in 
the value chain, etc.) among service providers. Available literature also does not 
mention the sources from which service providers receive market information, 
suggesting a gap in the support environment (multiple references).
Different medical associations exist to facilitate coordination both among private 
sector service providers and between them and other value chain players. FOGSI 
brings together OBGYN providers, and the Indian Medical Association (IMA) covers 
registered allopathic medical practitioners across India. Other associations bring 
together different branches within AYUSH medicine. For example, the National 
Integrated Medical Association (NIMA) groups Ayurveda and Unani practitioners 
from institutions recognized by the Central Council of Indian Medicine (multiple 
references).
Besides official medical associations, NGO- and donor-run associations provide 
coordination for specific service provider segments. For example, OBGYN and 
MBBS providers can enroll in the Dimpa Program—funded by USAID—to become 
part of the Dimpa Network, which increases access to affordable IC services for 
consumers by linking marketers and service providers (Patro, Singh, Srivastava, & 
Tanwar, 2012).
Public sector facilities are financed through government-allocated funds at the 
state level (Pillai & Singh, Urban Health Initiative, India: Progress and Results 
January 2009 to December 2013, 2014). The MoHFW has also implemented a 
public-private partnership (PPP) whereby it reimburses accredited private sector 
and NGO facilities for costs up to INR 2,000 (Uttar Pradesh (UP) and Bihar) per 
sterilization procedure (MoHFW, 2015). To further incentivize the provision of 
sterilization services, the MoHFW has implemented the National Family Planning 
Indemnity Scheme (NFPIS), which ensures that States and Union Territories process 
and pay for consumer claims in the event of complications, method failure, or 
death related to the procedure (MoHFW, 2015).
|   FSG14 
Even with allocated funding, public healthcare facilities have inadequate 
infrastructure and human resources, and they lack essential services, drugs, and 
supplies (Blanchard, Ghosh, Prakash, & Ramesh, 2015). For instance, there is a 
major gap in the availability of critical equipment and emergency drugs required 
for IUD insertion and removal, at both public and private facilities (Achyut, Khan, 
Nanda, & Verma, 2014; Expanding Contraceptive Use in Urban Uttar Pradesh: 
Quality of Care, 2010). Many public sector facilities below the DH level also lack 
adequate infrastructure and equipment to provide quality sterilization services 
(Achyut, Khan, Nanda, & Verma, 2014). Likewise, temporary FP camps have 
inadequate infrastructure and equipment for providing services (Expanding 
Contraceptive Use in Urban Uttar Pradesh: Quality of Care, 2010).
Adding to poor infrastructure, quality is also compromised by service providers 
that do not follow standard protocols, especially in terms of counseling about 
side-effects and product use (Expanding Contraceptive Use in Urban Uttar 
Pradesh: Quality of Care, 2010). Service providers also have user- and method-
related biases about providing spacing methods to lower-parity women, which 
restrict consumers’ access to FP (Achyut, et al., 2013).
The MoHFW has an existing quality assurance committee that establishes pre- 
and post-procedure guidelines for sterilization. It has also formed state- and 
district-level committees to ensure high-quality FP services (MoHFW, 2015). These 
committees focus on service delivery norms and training, with tools like reference 
manuals and provider handbooks (IFPS Technical Assistance Project (ITAP), 2012; 
MoHFW, 2015). Still, few service providers receive regular FP training, regardless 
of whether they practice in public or private facilities (Achyut, et al., 2013; Achyut, 
Khan, Nanda, & Verma, 2014).
Led by NGOs and donors, private players have begun to implement quality 
assurance programs and montoring and evaluation tools (Patro, Singh, Srivastava, 
& Tanwar, 2012; Public Health Foundation of India, 2016). Quality assurance tools 
include provider training and mentoring, as well as the design and distribution of 
communication materials and job aides tailored to the needs of providers (Pillai 
& Singh, Urban Health Initiative, India: Progress and Results January 2009 to 
December 2013, 2014). Client surveys prove their effectiveness, indicating that 
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providers who operate within private networks (e.g., Dimpa Network clinics) or 
as part of NGO programs tend to deliver higher-quality services to consumers 
(Expanding Contraceptive Use in Urban Uttar Pradesh: Quality of Care, 2010).
Labor capacity constraints aggravate the challenges involving quality. Existing 
service providers have an excessive workload and limited time (multiple references). 
This is especially the case for public sector facilities, which also face shortages in 
the number of dedicated FP counselors (Achyut, Khan, Nanda, & Verma, 2014; 
Pillai & Singh, Urban Health Initiative, India: Progress and Results January 2009 to 
December 2013, 2014).
The number of OBGYN and MBBS providers per 100,000 population in UP and 
Bihar is far lower than the national average in India (Central Bureau of Health 
Intelligence, 2015). The Indian average is 6 OBGYN providers per 100,000 
population; UP only has 2, and Bihar only has 1 OBGYN per 100,000 people. For 
MBBS providers, the Indian average is 70 per 100,000 population. UP only has 29 
and Bihar only has 37 MBBS providers per 100,000 people. In the AYUSH category, 
there are only Ayurvedic, Homeopathic, and Unani (AHU) providers in both UP and 
Bihar2 (Central Bureau of Health Intelligence, 2015), a disproportionate number 
of which are registered in Bihar (132 per 100,000 population) as compared to 
the national Indian rate (59 per 100,000 population) (Central Bureau of Health 
Intelligence, 2015).
RULES
Policy and regulations on FP service provisioning have changed significantly, moving 
from centralized mandates to decentralized planning to address local needs. 
Initiatives include the development of district action plans and the involvement 
of Panchayati Raj Institutions in FP (ITAP, 2012). Policy changes have also allowed 
for the introduction of new methods into public sector channels. For instance, the 
GoI included DMPA in its FP portfolio in 2016, enabling public sector facilities to 
administer it (Family Planning Division, MoHFW, 2016; Patro, Singh, Srivastava & 
Tanwar, 2012).
2 The National Health Profile (Central Bureau of Health Intelligence, 2015) only records the number of 
ASHU providers and does not include the count of Yoga and Naturopathy practitioners.
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Different government branches, such as the DCGI and the MoHFW, issue guidelines 
related to service delivery of medical products (Armand & Beer, 2006; MoHFW, 
2015). However, providers violate these guidelines in actual practice, as is the case 
with sterilization quality standards and counseling norms (Tandon, 2010).
3.2 OUTLET PROVIDERS
Outlet providers sell or give FP products to consumers. They include traditional 
outlets (TOs) like pharmacies and chemists, as well as non-traditional outlets (NTOs) 
like kirana shops and beauty parlors. They also include public sector outreach 
workers (e.g., ASHA) and government dispensaries.
CORE FUNCTIONS
Private sector outlet providers stock condoms, OCPs, ICs, and IUDs distributed 
through the commercial and SMO channels (multiple references). Traditional 
outlets stock both OTC and Rx products, and sell a vast majority of FP products 
(Pillai & Singh, Urban Health Initiative, India: Progress and Results January 2009 
to December 2013, 2014). TOs tend to stock products across price brackets, 
ranging from INR 3 for one cycle of SMO-marketed OCPs to over INR 2,000 for 
commercially marketed hormonal IUDs (multiple references). By contrast, NTOs 
sell mostly low-priced condoms and over-the-counter OCPs (multiple references). 
Public sector outlet providers fall under two main categories: government 
dispensaries and outreach workers. Government dispensaries stock government-
brand condoms (Nirodh) and OCPs (Mala-N) for free distribution to consumers 
at public healthcare facilities. They also stock non-branded IUDs (Cu-T 375 and 
Cu-T 380A), which service providers insert free of cost at public facilities. Outreach 
workers (e.g., ASHA) have government-brand condoms (Nirodh) and OCPs 
(Mala-N) for distribution within their communities (FHI 360, 2012; MoHFW, 2015; 
National Health Mission, 2015-16).
As part of the MoHFW’s Home Delivery of Contraceptives scheme, ASHA workers 
can charge INR 1 per pack of three condoms and INR 1 per cycle of OCPs (MoHFW, 
2015). Both ASHA workers and consumers in target communities have expressed 
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satisfaction with the scheme, but issues with supply chain management hinder 
the consistent availability of FP products (Basu & Green, 2012).
Outreach workers promote FP through direct interaction with the communities 
they work in, with activities like home visits, community events, and one-on-one 
counseling. Other types of outlet providers do passive promotion for FP. Those 
in the private sector usually have FP marketing collateral, such as danglers and 
posters, on display (multiple references). Similarly, government dispensaries are 
located within public sector healthcare facilities, which have posters promoting 
different FP practices and methods (MoHFW, 2013).
Promotional efforts have not always been successful because the messages aimed 
to attract new users have not decreased the resistance of the poor to using 
modern contraception (multiple references). For example, promotion of condoms 
at the outlet provider level is either fear-based and focused on HIV prevention 
(public sector and SMO condoms), or overly sexualized (private sector commercial 
condoms) (Begum, Dontra & Naik, 2014; Expanding Contraceptive Use in Urban 
Uttar Pradesh: Quality of Care, 2010).
SUPPORT ENVIRONMENT
Public sector outlet providers fall under a strict supply chain hierarchy managed by 
the MoHFW. The MoHFW coordinates between providers and across players along 
the public value chain. It also manages demand forecasting and other market 
information, and issues guidance on the distribution and delivery of different FP 
products (Bill & Melinda Gates Foundation, 2011).
Unlike the centrally coordinated public sector, existing literature suggests there are 
gaps in information sharing and guidance for private sector outlet providers. Existing 
literature also suggests a lack of formal coordination mechanisms both between 
private outlet providers and with other value chain players (multiple references). 
In fact, any formal coordination among private sector outreach workers happens 
through dedicated FP programs, if at all (Expanding Contraceptive Use in Urban 
Uttar Pradesh: Quality of Care, 2010; Pillai & Singh, Urban Health Initiative, India: 
Progress and Results January 2009 to December 2013, 2014).
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Most financial incentives for outlet providers target MoHFW outreach workers 
(multiple references). ASHA workers receive incentives for the following (MoHFW, 
2015; National Health Mission, 2015–16):
• Delaying a couple’s first child for two years after marriage (INR 500)
• Guaranteeing a three-year gap between a couple’s first and second children 
(INR 500)
• Persuading consumers to undergo sterilization (varies, INR 150–300)
• Ensuring that couples undergo sterilization after their second child (INR 1000)
• Counseling consumers to opt for IUD (select dates) and PPIUCD (year-round, 
INR 150)
Outreach workers also counsel consumers about product use and side effects to 
support the continued use of FP (Public Health Foundation of India, 2016; Urban 
Health Initiative, 2015). Yet unlike outreach workers, outlet providers rarely counsel 
consumers about drug side effects, as they are neither trained nor required to do 
so (Achyut, et al., 2013; Expanding Contraceptive Use in Urban Uttar Pradesh: 
Quality of Care, 2010).
RULES
The India Drugs and Cosmetics Acts of 1940 and 1945 that established specific 
regulations for manufacturing standards also regulate the storage and sales of 
FP products (Tandon, 2010). As previously stated (in Section 1: Manufacturers), 
different drug schedules regulate different FP products. Schedule R looks at 
condoms and “mechanical contraceptives” (Schedule R), and Schedules H and K 
focus on substances and drugs, like OCPs (Armand & Beer, 2006). Outlet providers 
can advertise Schedule K products and sell them over-the-counter, but can only 
sell Schedule H products (Rx) after seeing a doctor’s prescription (Armand & Beer, 
2006).
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In the scope of FP in India, consumers are typically defined as currently married 
men and women of reproductive age (15–49 years), with a heavier emphasis 
placed on currently married women (CMWs) in this age bracket. Most of the 
literature on consumers focuses on CMWs, yet some sources also look into other 
segments like males, adolescents, and family influencers.
As described in the Introduction, this section uses five key dimensions to understand 
the factors that limit the consumer’s ability to effectively engage in FP: awareness, 
availability and access, affordability, assured quality, and acceptability.
AWARENESS
Awareness of FP and different FP methods is high among both men and women, 
with almost universal awareness of female sterilization (multiple references). 
However, most women have gaps in information, especially on correct product 
usage and postpartum FP (PPFP) (multiple references). Many consumers also equate 
FP (Parivar Niyojan) to female sterilization and rarely consider male sterilization as 
an FP option (Char, Kulmala, & Saavala, 2009).
Sources of information about FP differ for women and men. In addition to receiving 
information through television, women discuss FP with outreach workers as well 
as with friends, neighbors, and families (Achyut, Calhoun, Mishra, & Nanda, 
2011; Idnani, Khan, Kumari, & Sebastian, 2012). Family influencers, particularly 
the husband and the mother-in-law, thus play a crucial role on a couple’s decisions 
regarding contraception and FP (Dixit, 2012; Rai & Unisa, 2013). Unlike women, 
who have many channels to access FP information, men receive information 
primarily through mass media (Char, Kulmala, & Saavala, 2009). Hence, although 
studies have shown that repeated exposure to mass- and mid-media contributes 
to a significant increase in modern contraceptive use (Chaudhury, Datta, & Roy, 
4. CONSUMERS
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2012), men feel that women have better and more direct access to FP information 
through outreach workers (Char, Kulmala, & Saavala, 2009; Char, Kulmala, & 
Saavala, 2011).
AVAILABILITY AND ACCESS
The majority of women have access to a healthcare facility within a reasonable 
distance. Nevertheless, access to FP is still a barrier in rural areas, where consumers 
have difficulty obtaining low-cost, high-quality services (Rai & Unisa, 2013). 
Adding to that, many facilities do not have consistent availability of all FP methods 
(multiple references), and most public sector facilities have experienced product 
stock-outs (Achyut, Calhoun, Mishra, & Nanda, 2011; Bill & Melinda Gates 
Foundation, 2011).
Private sector distribution channels do not face severe stock-out issues. In the 
case of condoms, for instance, consumers have low brand loyalty and product 
stock-outs are rare. The unavailability of one brand does not necessarily prevent 
consumers from using condoms as an FP method. OCP stock-outs do present a 
barrier to continued use because consumers have strong brand loyalty. Given that 
stock-outs are more common for SMO than for commercial brands, they limit 
access for lower-parity consumers who prefer the subsidized SMO products (Bill & 
Melinda Gates Foundation, 2011). 
Biases further limit consumers’ access to comprehensive FP. Service provider 
biases regarding client profiling and particular methods prevent certain consumer 
segments from accessing FP (Achyut, et al., 2013). Many consumers also feel 
uncomfortable or embarrassed when purchasing FP products from outlet providers 
due to socio-cultural norms involving contraception and FP (Char, Kulmala, & 
Saavala, 2011). Men are the primary purchasers of condoms and OCPs, leaving 
women subject to their husbands’ willingness to buy a particular product or a 
specific brand (Measurement, Learning & Evaluation (MLE) Project, 2014).
AFFORDABILITY
FP methods are available across price ranges, and affordability is not a commonly 
cited issue contributing to discontinuation or lack of use (multiple references). Still, 
certain segments of the population cannot afford comprehensive FP at facilities of 
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their choice. This is the case largely for lower-parity consumers that need service-
dependent FP methods like ICs, IUDs, and sterilization (ITAP, 2012). For example, 
ICs have not been affordable for lower-parity CMWs, as they were not offered 
for free through public sector channels before 2016 (Ahmad, Dixit, Khan, & Pillai, 
2015; Bill & Melinda Gates Foundation, 2011; Expanding Contraceptive Use in 
Urban Uttar Pradesh: Quality of Care, 2010).
To counter some of these challenges, the MoHFW has implemented a wage-loss 
compensation (WLC) scheme for acceptors of sterilization. It seeks to ensure that 
income lost due to the procedure is not a deterrent to adoption (MoHFW, 2015). 
WLC ranges from INR 1,000 to INR 2,200 depending on the type of procedure 
(interval or postpartum tubectomy, or vasectomy) and on the type of facility 
(MoHFW, 2015).
ASSURED QUALITY
Consumers have an overwhelming fear of infertility and of the side effects caused 
by different FP methods (Campbell, Diamond-Smith, & Madan, 2012; Prusty, 
2014). In fact, discontinuation due to side effects is particularly high for OCPs and 
IUDs, and is more common in urban than in rural areas (Dixit, 2012). Although 
there are real health concerns, women also have incorrect beliefs about the side 
effects of different FP methods, mainly due to misinformation. Studies show 
that some women acknowledge the perception of side effects as being potential 
exaggerations by other women who have faced them. Many have indeed expressed 
that they would be more likely to use FP if service providers disproved their fears 
(Campbell, Diamond-Smith, & Madan, 2012). However, only a limited number 
of CMWs are fully informed about the potential side effects of using different 
FP methods (Achyut, Khan, Nanda, & Verma, 2014; Ahmad, Dixit, Khan, & Pillai, 
2015).
Consumers often perceive free distribution condoms to be of poor quality (NACO). 
The same cannot be said about service-dependent FP methods offered free of 
cost at public facilities. Despite low quality standards in FP service provisioning, 
the majority of women are satisfied with the quality of service they receive. The 
only difference in the perception of quality, which is higher in private than in 
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public sector healthcare facilities, lies in consumers preferring closer interpersonal 
relationships with service providers (Achyut, Khan, Nanda, & Verma, 2014).
ACCEPTABILITY AND CONTINUED USE
Modern contraceptive use in UP and Bihar, measured in terms of mCPR, is 
lower among urban poor than among rural consumers (Dadhwal, et al., 2015). 
Besides access and affordability, consumer fears, myths, and misconceptions are 
significant barriers affecting the demand and uptake of FP methods (Expanding 
Contraceptive Use in Urban Uttar Pradesh: Quality of Care, 2010).
Method discontinuation also plays a role in the acceptability of FP. The highest 
discontinuation rates within the first year are for ICs, followed by OCPs and 
condoms (Barden-O’Fallon, Calhoun, Montana, Nanda, & Speizer, 2014). Aside 
from a desire to conceive, the most commonly reported reason for discontinuation 
(Barden-O’Fallon, Calhoun, Montana, Nanda, & Speizer, 2014), many consumers 
suspend method use even though they need contraception. A significant 
proportion of them cite side effects and health problems as their reasons (Dixit, 
2012; Joshi, Nagar, Sharma, & Sharma, 2014). IUD users, for example, discontinue 
either within four months of insertion (suggesting problems with the method) or 
after two years of use (suggesting a desire to get pregnant) (Chander Modi, et al., 
2011).
Women who have used multiple methods are likely to have discontinued one 
method in pursuit of another, more effective one. After condom users, these 
women are also the most likely to have an unwanted pregnancy (Barden-O’Fallon, 
Calhoun, Montana, Nanda, & Speizer, 2014; Knowledge, Attitudes, Beliefs, and 
Perception of the North Indian Population Toward Adoption of Contraceptive 
Practices, 2012). It comes as no surprise, therefore, that improvements in 
service approach and quality—educating consumers on reproductive anatomy, 
product use demonstrations, counseling, etc.—result in significant reductions in 
discontinuation (Expanding Contraceptive Use in Urban Uttar Pradesh: Quality of 
Care, 2010).
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As this document shows, the bulk of existing literature on the FP market in 
India focuses on providers (namely service providers and outreach workers) and 
consumers. However, upstream value chain players in the public and private sectors 
also have great potential for driving the market and would warrant further study.
In addition, while nonprofit organizations and private companies have conducted 
independent research on different parts of the value chain, there is no one 
consolidated resource to understand how these players together have shaped the 
market. While this literature review highlights key findings from existing sources, 
consolidating collective knowledge should be a priority for the field in the future.
AREAS FOR FURTHER 
ENQUIRY
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LIST OF ABBREVIATIONS
AHU Subset of AYUSH doctors: Ayurveda, Homeopathy, Unani
ANM Auxiliary nurse and midwife
ASHA Accredited Social Health Activist
ASHU Subset of AYUSH doctors: Ayurveda, Siddha, Homeopathy, Unani
AYUSH Ayurveda, Yoga and Naturopathy, Unani, Siddha, and 
Homoeopathy doctors
CFA Carrying and forwarding agent
CHC Community health center
CMW Currently married women
Condoms Generally refers to male condoms
DCGI Drug Controller General of India
DGO Diploma in Gynecology & Obstetrics 
DH District hospital
DMPA Depot Medroxyprogesterone Acetate
FOGSI Federation of Obstetric and Gynecological Societies of India
FP Family planning
GoI Government of India
HLL HLL Lifecare Limited (formerly Hindustan Latex Limited)
IC Injectable contraceptive
IDPL Indian Drug and Pharmaceutical Ltd.
IMA Indian Medical Association
INR Indian rupee
ISO International Organization for Standardization
IUD/IUCD Intra-uterine device/Intra-uterine contraceptive device
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LHV Lady health visitors
MBBS Latin abbreviation for Bachelor of Medicine and Bachelor of 
Surgery (Medicinae Baccalaureus, Baccalaureus Chirurgiae)
mCPR Modern contraceptive prevalence rate
MoHFW Ministry of Health and Family Welfare
MR Medical representative
NACO National AIDS Control Organization
NFPIS National Family Planning Indemnity Scheme
NGO Non-governmental organization
NIMA National Integrated Medical Association
NRHM National Rural Health Mission
NTO Non-traditional outlet
OBGYN Obstetrician/Gynecologist
OCP Oral contraceptive pill
OTC Over-the-counter
PHC Primary health center
PPFP Postpartum family planning
PPIUCD Postpartum intra-uterine contraceptive device
PPP Public-private partnership
RMP Rural medical practitioner 
Rx Prescription-only product
SACS State AIDS Prevention and Control Societies
SMO Social marketing organization
TO Traditional outlet
UNFPA United Nations Population Fund
UP Uttar Pradesh
USAID United States Agency for International Development
USFDA United States Food and Drug Administration
WHO World Health Organization
WLC Wage-loss compensation
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